Ken Griffin Da32 Life Science Tech Acquisition Corp. Transaction History

Citadel Advisors LLC

  • $483 Billion
  • Q2 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Aug 14, 2023
SELL
$10.13 - $10.31 $1.45 Million - $1.48 Million
-143,192 Reduced 19.69%
584,130 $5.99 Million
Q1 2023

May 15, 2023
BUY
$9.94 - $10.2 $58,268 - $59,792
5,862 Added 0.81%
727,322 $7.36 Million
Q4 2022

Feb 14, 2023
BUY
$9.73 - $10.08 $4,135 - $4,284
425 Added 0.06%
721,460 $7.21 Million
Q3 2022

Nov 14, 2022
BUY
$9.68 - $9.79 $909 - $920
94 Added 0.01%
721,035 $6.99 Million

About DA32 Life Science Tech Acquisition Corp.

DALS Quotes by TradingView
  • Ticker DALS
  • Exchange NASDAQ
  • Sector Financial Services
  • Industry Shell Companies
  • Shares Outstandng 20,650,000
  • Description
  • DA32 Life Science Tech Acquisition Corp. does not have significant operations. It focuses on effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or related business combination with one or more businesses. The company intends to identify business combination targets in the biotechnology and life science...
More about DALS
Track Ken Griffin's Portfolio

Track Ken Griffin Portfolio

Follow Ken Griffin (Citadel Advisors LLC) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Citadel Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Citadel Advisors LLC and Ken Griffin with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email